Key facts
- This page summarizes Alexis DeSieno's Form 4 filing for Cardlytics, Inc. (CDLX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 Mar 2025, 20:54.
Alexis DeSieno - 19 Mar 2025 Form 4 Insider Report for Cardlytics, Inc. (CDLX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CDLX
- Reported as of
- 19 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2025, 20:54:00 UTC
- Prior SEC filing
- 18 Feb 2025
- Next SEC filing
- 03 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Lynton, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexis DeSieno filed Form 4 for Cardlytics, Inc. (CDLX) on 21 Mar 2025.
Change
- Previous filing in this sequence was filed on 18 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDLX
transaction
Derivative
Performance Stock Unit
Award
- Transaction value
- $0
- Shares
- +50,625
- Change %
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,625
- Exercise price
- Footnotes
- F1, F2
CDLX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +135,000
- Change %
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 135,000
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F2
The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Footnote F3
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F4
50% of the shares underlying the RSU award will vest on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.